Table 1.
Patient Characteristics (N = 28)
| Characteristic | Value |
|---|---|
| Age, mean (range), y | 50 (25‐80) |
| Sex, n (%) | |
| Men | 9 (32) |
| Women | 19 (68) |
| ECOG performance status, n (%) | |
| 0 | 16 (57) |
| 1 | 11 (39) |
| 2 | 1 (4) |
| Tumor type, n (%) | |
| Colorectal cancer | 6 (21) |
| Breast cancer | 3 (11) |
| Pancreatic cancer | 3 (11) |
| Non–small cell lung cancer | 2 (7) |
| Glioblastoma multiforme | 2 (7) |
| HCC | 2 (7) |
| Salivary gland cancer | 2 (7) |
| Othera | 8 (29) |
| Prior systemic anticancer therapies, n (%) | |
| 1‐3 | 14 (50) |
| >3 | 14 (50) |
Abbreviation: ECOG, Eastern Cooperative Oncology Group; HCC, hepatocellular carcinoma.
a
Other tumors (n=1 each): adenocystic, adrenal, esophageal, multiple myeloma, neuroendocrine, paraganglioma, renal, and sarcoma.